From 14-15 June 2023, a group of LML members attended Sustainable Health Innovation, Grand Challenges & the Law, a symposium hosted by the University of Copenhagen.
This event marked the conclusion of the Collaborative Innovation Program In Biomedical Innovation Law (CeBIL). International experts discussed the legal, ethical, social, and policy implications of select challenges in the health and life sciences. Topics included sustainable innovation, pandemic preparedness, antimicrobial resistance, biologics, advanced medical computing, AI, orphan drugs, and repurposed drugs.
The conference was a forum for presenting novel insights from research conducted as part of the CeBIL collaboration. It identified emerging areas of research required to address ‘grand challenges’ in the future.
LML has been a core partner of CeBIL for the duration of the 5.5 year project. Our members led a study on repurposing known drugs for new medical uses. They also contributed to a cross-cutting Synergy study with evidence-based IP research and a body of work on data sharing.